Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Malherbe

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|June 26, 2020
Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth DevelopmentDelphine C Malherbe, Constantinos Kurt Wibmer, Molati Nonyane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2021
Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human DonorDavid A Spencer, Delphine C Malherbe, Néstor Vázquez Bernat, et al.
Plos One|December 20, 2018
Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadthValentine U Chukwuma, Nurgun Kose, D Noah Sather, et al.
Plos Pathogens|May 18, 2022
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER regionClara T Schoeder, Pavlo Gilchuk, Amandeep K Sangha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2016
Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope ImmunogensAnn J Hessell, Delphine C Malherbe, Franco Pissani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2021
Virus Control in Vaccinated Rhesus Macaques Is Associated with Neutralizing and Capturing Antibodies against the SHIV Challenge Virus but Not with V1V2 Vaccine-Induced Anti-V2 Antibodies AloneAnn J Hessell, Liuzhe Li, Delphine C Malherbe, et al.
Frontiers in Immunology|March 4, 2021
Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV ChallengeDelphine C Malherbe, Lo Vang, Jason Mendy, et al.
Journal of Virology|July 26, 2013
Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaquesJ Pablo Jaworski, James Kobie, Zachary Brower, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Nature Communications|January 9, 2020
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunityMariya B Shapiro, Tracy Cheever, Delphine C Malherbe, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|June 26, 2020
Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth DevelopmentDelphine C Malherbe, Constantinos Kurt Wibmer, Molati Nonyane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2021
Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human DonorDavid A Spencer, Delphine C Malherbe, Néstor Vázquez Bernat, et al.
Plos One|December 20, 2018
Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadthValentine U Chukwuma, Nurgun Kose, D Noah Sather, et al.
Plos Pathogens|May 18, 2022
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER regionClara T Schoeder, Pavlo Gilchuk, Amandeep K Sangha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2016
Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope ImmunogensAnn J Hessell, Delphine C Malherbe, Franco Pissani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2021
Virus Control in Vaccinated Rhesus Macaques Is Associated with Neutralizing and Capturing Antibodies against the SHIV Challenge Virus but Not with V1V2 Vaccine-Induced Anti-V2 Antibodies AloneAnn J Hessell, Liuzhe Li, Delphine C Malherbe, et al.
Frontiers in Immunology|March 4, 2021
Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV ChallengeDelphine C Malherbe, Lo Vang, Jason Mendy, et al.
Journal of Virology|July 26, 2013
Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaquesJ Pablo Jaworski, James Kobie, Zachary Brower, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Nature Communications|January 9, 2020
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunityMariya B Shapiro, Tracy Cheever, Delphine C Malherbe, et al.
Pageof 6